Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | RAB9A | P51151 | 6/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | CASP3 | P42574 | 1/20 | 0.55 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.55 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.55 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.54 |
| ▸ | STS | P08842 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 4/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.53 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | PLAU | P00749 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL71493 | 0.92 | L3MBTL1 (0.56) | L3MBTL1MAPTSRD5A2ALDH1A1RAB9A | |
| SCHEMBL6201900 | 0.90 | RAB9A (0.59) | L3MBTL1MAPTSRD5A2RAB9ASMN1; SMN2 | |
| SCHEMBL7129800 | 0.89 | MAPT (0.80) | L3MBTL1MAPTSRD5A2RAB9ASMN1; SMN2 | |
| SCHEMBL7167952 | 0.86 | SRD5A2 (0.62) | L3MBTL1MAPTSRD5A2ALDH1A1RAB9A | |
| SCHEMBL24800 | 0.85 | MAPT (0.73) | L3MBTL1MAPTSRD5A2ALDH1A1RAB9A | |
| SCHEMBL8956299 | 0.85 | SRD5A2 (0.60) | L3MBTL1MAPTSRD5A2RAB9ALMNA | |
| SCHEMBL13052378 | 0.85 | MAPK1 (0.53) | L3MBTL1MAPTSRD5A2ALDH1A1RAB9A | |
| SCHEMBL10767044 | 0.85 | MEN1 (0.60) | L3MBTL1MAPTSRD5A2ALDH1A1RAB9A | |
| SCHEMBL10767038 | 0.85 | SRD5A2 (0.60) | L3MBTL1MAPTSRD5A2RAB9ALMNA | |
| SCHEMBL5260372 | 0.83 | SRD5A2 (0.89) | L3MBTL1MAPTSRD5A2RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114230447-B | Continuous flow preparation method of 4' -fluoro-2-phenyl acetophenone | 河南豫辰药业股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-117695992-A | Full-continuous chemical synthesis device and method for atorvastatin calcium mother nucleus | 复旦大学 | 2024-03-15 | — | — | CN | claimed |
| CN-113755862-B | Method for preparing aromatic alpha-diketone compound by electrochemical oxidation | 西南大学 | 2022-08-19 | — | — | CN | claimed |
| CN-111170856-B | Preparation method and application of fluoroolefin | 云南民族大学 | 2022-04-15 | — | — | CN | claimed |
| CN-114230447-A | Continuous flow preparation method of 4' -fluoro-2-phenylacetophenone | 河南豫辰药业股份有限公司 | 2022-03-25 | — | — | CN | claimed |
| CN-113755862-A | Method for preparing aromatic alpha-diketone compound by electrochemical oxidation | 西南大学 | 2021-12-07 | — | — | CN | claimed |
| CN-103724175-A | Synthetic method of atorvastatin intermediate alpha-bromine-4-fluorophenyl benzyl ketone | ANQING JINQUAN PHARM CO LTD | 2014-04-16 | — | — | CN | claimed |
| CN-101307009-A | New synthetic method for (earth)4-fluor-alpha-(2-methyl-1-oxypropyl )-gamma-oxo-N, beta-diphenyl benzene butanamide | ZHEJIANG JINGXIN PHARMACEUTICA (CN) | 2008-11-19 | — | — | CN | claimed |
| CN-119936244-A | Method for detecting aldehyde genotoxic impurities in atorvastatin calcium | 华北制药集团新药研究开发有限责任公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-118908819-B | Preparation method of organic ketone compound under synergistic catalysis of light and metal | 延安大学 | 2025-04-18 | — | — | CN | disclosed |
| CN-119318997-B | Magnetic resin immobilized ionic liquid heteropolyacid catalyst and preparation method and application thereof | 浙江先锋科技集团股份有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-119318997-A | Magnetic resin immobilized ionic liquid heteropolyacid catalyst and preparation method and application thereof | 浙江先锋科技集团股份有限公司 | 2025-01-17 | — | — | CN | disclosed |
| CN-118908819-A | Preparation method of organic ketone compound under synergistic catalysis of light and metal | 延安大学 | 2024-11-08 | — | — | CN | disclosed |
| CN-114230447-B | Continuous flow preparation method of 4' -fluoro-2-phenyl acetophenone | 河南豫辰药业股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| US-20020086886-A1 | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors | G.D. SEARLE & CO. | 2002-07-04 | — | — | US | disclosed |
| EP-0995747-A1 | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors | G.D. SEARLE & CO. (US) | 2000-04-26 | — | — | EP | disclosed |
| WO-1996036617-A1 | SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-11-21 | — | — | WO | disclosed |
| EP-0006254-B1 | BENZOIN OXIME DERIVATIVES, PROCESS FOR THEIR PREPARATION, COMPOSITIONS CONTAINING SUCH DERIVATIVES AND METHOD FOR THEIR USE AS FUNGICIDES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1982-12-22 | — | — | EP | disclosed |
| US-4304789-A | Benzoin oxime fungicides | SHELL OIL COMPANY (US) | 1981-12-08 | — | — | US | disclosed |
| EP-0006254-A1 | Benzoin oxime derivatives, process for their preparation, compositions containing such derivatives and method for their use as fungicides | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1980-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020086886-A1 | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors | ALOX5, PTGES2, PTGS2 | L3MBTL1 3843/4885MAPT 4859/4885SRD5A2 438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.